StockData
Skinvisible, Inc. logo

Skinvisible, Inc. (SKVI) stock

SKVIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.16+0.00 (+0.06%)

Close on Oct 19, 2026Market cap $843.54KP/E –Yield –

Skinvisible pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Skinvisible's pe ratio was 4.8× on Apr 30, 2019.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2019Apr 30, 20194.8×−27.1
2018Dec 31, 201831.8×–

More Skinvisible figures

See a number that looks wrong?